生体電気医療の世界市場：タイプ・製品・用途・エンドユーザー・地域別の予測 (～2030年)

生体電気医療の市場規模は予測期間中に6.53%のCAGRで成長すると予測されています。

生体電気医療産業は、世界的な慢性疾患の有病率の上昇や、参入事業者による戦略的イニシアチブの増加によって牽引されています。世界保健機関によると、2019年には1,800万人が関節リウマチに罹患し、その70％が女性で55％が55歳以上とされています。さらに、Crohn's & Colitis UKは、2022年までに英国の123人に1人がクローン病または潰瘍性大腸炎に罹患すると推定しています。高コストの生体電気医療機器が市場成長を妨げると懸念されていますが、それにもかかわらず、参入企業による臨床試験の拡大と投資の増加が業界に有益な展望をもたらすと期待されています。

地域別洞察

北米市場は2022年に38.01%で最大の市場シェアを占め、予測期間中は4.71%のCAGRで推移し、2030年にはおよそ160億米ドルの規模に成長すると予測されています。また、アジア太平洋地域は予測期間中にCAGR 8.99％でもっとも高い成長率を示すと予想されています。

北米の生体電気医療市場の将来は依然として明るく、継続的な拡大が期待されています。医療インフラへの投資と最新医療ソリューションの認知度向上が市場成長をさらに促進すると予測されています。既存企業も新規参入企業も、より良い手術結果に対するニーズの高まりに対応するため、技術的改善を活用し、こうした可能性をつかむ準備ができています。

欧州市場は、技術の改善、医療費の上昇、慢性疾患の有病率の増加により、第2位の市場シェアを占めています。さらに、ドイツの生体電気医療市場が最大の市場シェアを持ち、フランスの生体電気医療市場は欧州でもっとも急速に拡大すると予測されています。

アジア太平洋市場は、患者人口の多さ、慢性疾患の有病率の増加、有利な規制政策により、2023年から2032年の間にもっとも急速に発展すると予測されています。また、大手企業がこの地域に絶えず進出しており、地域市場の成長を加速させています。中国が最大のシェアを占め、インドはもっとも急速に拡大する市場となる見込みです。

当レポートでは、世界の生体電気医療の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

• 概要
• 促進要因
  • 世界中で慢性疾患の発生が増加
  • 参入企業による戦略的取り組みの高まり
• 抑制要因
  • 生体電気医療機器に関連する高コスト
• 機会
  • 生体電気医療の臨床試験の増加
  • 参入企業による生体電気医療への投資の増加

第5章 市場要因分析

• ポーターのファイブフォース分析
• COVID-19が市場に与える影響

第6章 世界の生体電気医療市場：製品別

• 植込み型除細動器
• 心臓ペースメーカー
• 人工内耳
• 脊髄刺激装置
• 脳深部刺激装置
• 経皮電気神経刺激装置
• 仙骨神経刺激装置
• 迷走神経刺激装置
• その他

第7章 世界の生体電気医療市場：タイプ別

• 埋め込み型電気治療デバイス
• 非侵襲性電気治療デバイス

第8章 世界の生体電気医療市場：用途別

• 不整脈
• 疼痛管理
• 感音難聴
• パーキンソン病
• 震え
• うつ
• てんかん
• 尿失禁および便失禁
• その他

第9章 世界の生体電気医療市場：エンドユーザー別

• 病院
• 研究機関
• その他

第10章 世界の生体電気医療市場：地域別

• 概要
• 北米
• 欧州
• アジア太平洋
• その他の地域

第11章 競合情勢

• 開発件数でトップの企業
• 主な展開・成長戦略
• 主要企業の財務マトリックス

第12章 企業プロファイル

• ABBOTT
• BOSTON SCIENTIFIC CORPORATION
• ALEVA NEUROTHERAPEUTICS
• COCHLEAR LTD.
• LIVANOVA PLC
• MEDTRONIC
• BIOTRONIK
• CHARCO NEUROTECH
• NEVRO CORP
• ELECTROCORE, INC

第13章 付録

LIST OF TABLES

• TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
• TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
• TABLE 3 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 4 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 5 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR CARDIAC PACEMAKERS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 6 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR COCHLEAR IMPLANTS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 7 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR SPINAL CORD STIMULATORS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 8 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR DEEP BRAIN STIMULATORS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 9 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 10 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR SACRAL NERVE STIMULATORS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 11 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR VAGUS NERVE STIMULATORS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 12 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 13 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 14 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR IMPLANTABLE ELECTROCEUTICAL DEVICES, BY REGION, 2019-2032 (USD BILLION)
• TABLE 15 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR NON-INVASIVE ELECTROCEUTICAL DEVICES, BY REGION, 2019-2032 (USD BILLION)
• TABLE 16 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 17 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR ARRHYTHMIA, BY REGION, 2019-2032 (USD BILLION)
• TABLE 18 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR PAIN MANAGEMENT, BY REGION, 2019-2032 (USD BILLION)
• TABLE 19 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR SENSORINEURAL HEARING LOSS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 20 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR PARKINSON'S DISEASE, BY REGION, 2019-2032 (USD BILLION)
• TABLE 21 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR TREMOR, BY REGION, 2019-2032 (USD BILLION)
• TABLE 22 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR DEPRESSION, BY REGION, 2019-2032 (USD BILLION)
• TABLE 23 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR EPILEPSY, BY REGION, 2019-2032 (USD BILLION)
• TABLE 24 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR URINARY AND FECAL INCONTINENCE, BY REGION, 2019-2032 (USD BILLION)
• TABLE 25 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 26 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 27 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR HOSPITALS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 28 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR RESEARCH INSTITUTES, BY REGION, 2019-2032 (USD BILLION)
• TABLE 29 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 30 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY REGION, 2019-2032 (USD BILLION)
• TABLE 31 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
• TABLE 32 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 33 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 34 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 35 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 36 US: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 37 US: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 38 US: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 39 US: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 40 CANADA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 41 CANADA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 42 CANADA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 43 CANADA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 44 EUROPE: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
• TABLE 45 EUROPE: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 46 EUROPE: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 47 EUROPE: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 48 EUROPE: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 49 GERMANY: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 50 GERMANY: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 51 GERMANY: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 52 GERMANY: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 53 FRANCE: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 54 FRANCE: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 55 FRANCE: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 56 FRANCE: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 57 UK: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 58 UK: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 59 UK: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 60 UK: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 61 ITALY: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 62 ITALY: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 63 ITALY: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 64 ITALY: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 65 SPAIN: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 66 SPAIN: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 67 SPAIN: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 68 SPAIN: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 69 REST OF EUROPE: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 70 REST OF EUROPE: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 71 REST OF EUROPE: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 72 REST OF EUROPE: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 73 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
• TABLE 74 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 75 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 76 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 77 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 78 CHINA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 79 CHINA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 80 CHINA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 81 CHINA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 82 INDIA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 83 INDIA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 84 INDIA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 85 INDIA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 86 JAPAN: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 87 JAPAN: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 88 JAPAN: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 89 JAPAN: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 90 AUSTRALIA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 91 AUSTRALIA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 92 AUSTRALIA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 93 AUSTRALIA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 94 SOUTH KOREA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 95 SOUTH KOREA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 96 SOUTH KOREA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 97 SOUTH KOREA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 98 REST OF ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 99 REST OF ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 100 REST OF ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 101 REST OF ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 102 REST OT THE WORLD: BIOELECTRIC MEDICINE MARKET, BY REGION, 2019-2032 (USD BILLION)
• TABLE 103 REST OF THE WORLD: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 104 REST OF THE WORLD: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 105 REST OF THE WORLD: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 106 REST OF THE WORLD: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 107 MIDDLE EAST: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 108 MIDDLE EAST: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 109 MIDDLE EAST: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 110 MIDDLE EAST: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 111 AFRICA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 112 AFRICA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 113 AFRICA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 114 AFRICA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 115 LATIN AMERICA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 116 LATIN AMERICA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 117 LATIN AMERICA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
• TABLE 118 LATIN AMERICA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 119 MAJOR PLAYERS IN THE GLOBAL BIOELECTRIC MEDICINE MARKET
• TABLE 120 MOST ACTIVE PLAYERS IN THE GLOBAL BIOELECTRIC MEDICINE MARKET
• TABLE 121 PRODUCT LAUNCH
• TABLE 122 PRODUCT APPROVAL
• TABLE 123 ACQUISITION
• TABLE 124 INVESTMENT
• TABLE 125 EXPANSION
• TABLE 126 ABBOTT: PRODUCTS OFFERED
• TABLE 127 ABBOTT: KEY DEVELOPMENTS
• TABLE 128 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
• TABLE 129 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS
• TABLE 130 ALEVA NEUROTHERAPEUTICS: PRODUCT OFFERED
• TABLE 131 ALEVA NEUROTHERAPEUTICS: KEY DEVELOPMENTS
• TABLE 132 COCHLEAR LTD.: PRODUCTS OFFERED
• TABLE 133 COCHLEAR LTD.: KEY DEVELOPMENTS
• TABLE 134 LIVANOVA PLC: PRODUCTS OFFERED
• TABLE 135 LIVANOVA PLC: KEY DEVELOPMENTS
• TABLE 136 MEDTRONIC: PRODUCTS OFFERED
• TABLE 137 MEDTRONIC.: KEY DEVELOPMENTS
• TABLE 138 BIOTRONIK: PRODUCTS OFFERED
• TABLE 139 BIOTRONIK.: KEY DEVELOPMENTS
• TABLE 140 CHARCO NEUROTECH: PRODUCTS OFFERED
• TABLE 141 CHARCO NEUROTECH: KEY DEVELOPMENTS
• TABLE 142 NEVRO CORP: PRODUCTS OFFERED
• TABLE 143 NEVRO CORP: KEY DEVELOPMENTS
• TABLE 144 ELECTROCORE, INC: PRODUCTS OFFERED
• TABLE 145 ELECTROCORE, INC: KEY DEVELOPMENTS

LIST OF FIGURES

• FIGURE 1 MARKET SYNOPSIS
• FIGURE 2 GLOBAL BIOELECTRIC MEDICINE MARKET
• FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
• FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE BIOELECTRIC MEDICINE MARKET
• FIGURE 5 DRIVER IMPACT ANALYSIS
• FIGURE 6 RESTRAINT IMPACT ANALYSIS
• FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BIOELECTRIC MEDICINE MARKET
• FIGURE 8 GLOBAL BIOELECTRIC MEDICINE MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2022 TO 2032 (USD BILLION)
• FIGURE 9 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2022 & 2032 (USD BILLION)
• FIGURE 10 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY PRODUCT,
• FIGURE 11 GLOBAL BIOELECTRIC MEDICINE MARKET, TYPE SEGMENT ATTRACTIVENESS, 2022 TO 2032 (USD BILLION)
• FIGURE 12 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2022 & 2032 (USD BILLION)
• FIGURE 13 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY TYPE,
• FIGURE 14 GLOBAL BIOELECTRIC MEDICINE MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022 TO 2032 (USD BILLION)
• FIGURE 15 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2022 & 2032 (USD BILLION)
• FIGURE 16 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY APPLICATION,
• FIGURE 17 GLOBAL BIOELECTRIC MEDICINE MARKET, END USER SEGMENT ATTRACTIVENESS, 2022 TO 2032 (USD BILLION)
• FIGURE 18 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY END USER, 2022 & 2032 (USD BILLION)
• FIGURE 19 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY END USER,
• FIGURE 20 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY REGION, 2022 & 2032 (USD BILLION)
• FIGURE 21 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY REGION,
• FIGURE 22 NORTH AMERICA MARKET ANALYSIS: BIOELECTRIC MEDICINE MARKET, 2019-2032 (USD BILLION)
• FIGURE 23 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2022 & 2032 (USD BILLION)
• FIGURE 24 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET SHARE (%), BY COUNTRY,
• FIGURE 25 EUROPE MARKET ANALYSIS: BIOELECTRIC MEDICINE MARKET, 2019-2032 (USD BILLION)
• FIGURE 26 EUROPE: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2022 & 2032 (USD BILLION)
• FIGURE 27 EUROPE: BIOELECTRIC MEDICINE MARKET SHARE (%), BY COUNTRY,
• FIGURE 28 ASIA-PACIFIC MARKET ANALYSIS: BIOELECTRIC MEDICINE MARKET, 2019-2032 (USD BILLION)
• FIGURE 29 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2022 & 2032 (USD BILLION)
• FIGURE 30 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET SHARE (%), BY COUNTRY,
• FIGURE 31 REST OF THE WORLD MARKET ANALYSIS: BIOELECTRIC MEDICINE MARKET, 2019-2032 (USD BILLION)
• FIGURE 32 REST OT THE WORLD: BIOELECTRIC MEDICINE MARKET, BY REGION, 2022 & 2032 (USD BILLION)
• FIGURE 33 REST OT THE WORLD: BIOELECTRIC MEDICINE MARKET SHARE (%), BY REGION,
• FIGURE 34 BENCHMARKING OF MAJOR COMPETITORS
• FIGURE 35 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL BIOELECTRIC MEDICINE MARKET
• FIGURE 36 GLOBAL BIOELECTRIC MEDICINE MARKET: COMPETITIVE LANDSCAPE
• FIGURE 37 SALES,
• FIGURE 38 R&D,
• FIGURE 39 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 40 ABBOTT: SWOT ANALYSIS
• FIGURE 41 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 42 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
• FIGURE 43 COCHLEAR LTD.: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 44 COCHLEAR LTD.: SWOT ANALYSIS
• FIGURE 45 LIVANOVA PLC: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 46 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 47 MEDTRONIC: SWOT ANALYSIS
• FIGURE 48 NEVRO CORP: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 49 ELECTROCORE, INC: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 50 ELECTROCORE, INC: SWOT ANALYSIS

Global Bioelectric Medicine Market Research Report Information by Type (Implantable Electroceutical Devices and Non-invasive Electroceutical Devices), by Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, And Others), By Application (Arrhythmia, Pain Management, Sensorineural Hearing Loss, Epilepsy, And Others), By End User (Hospitals & Clinics, ASCs, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2030

Market Overview

The Bioelectric Medicine Market is expected to expand at a compound annual growth rate (CAGR) of 6.53% over the projected period. The Bioelectric Medicine industry is being driven by rising prevalence of chronic diseases around the world, as well as increased strategic initiatives by industry participants. According to the World Health Organization, 18 million individuals suffered from rheumatoid arthritis in 2019, with 70% of them being women and 55% being over the age of 55. Furthermore, Crohn's & Colitis UK estimated that one in every 123 persons in the UK will have Crohn's disease or ulcerative colitis by 2022. However, the high cost of bioelectric medical devices is projected to hinder global market growth. Nonetheless, expanding clinical trials for bioelectric medicine and increased investment in bioelectric medicine by market participants are expected to generate profitable prospects for the industry.

The increasing prevalence of chronic diseases around the world is considerably contributing to the expansion of bioelectric medicine. Chronic diseases, including chronic pain conditions, neurological disorders, inflammatory diseases, and metabolic disorders, place a significant strain on healthcare systems and have a negative influence on patients' quality of life. Traditional treatment approaches, such as medicines and surgery, may have limited success or carry concerns of side effects for some people. The increasing prevalence of disorders, together with bioelectric medicine's prospective applicability in these circumstances, is driving up demand for bioelectric medicine products. For example, deep brain stimulation (DBS) has been proven to be effective in treating Parkinson's disease symptoms by regulating aberrant neural activity. Similarly, neuromodulation devices such as vagus nerve stimulation (VNS) have showed efficacy in lowering seizure frequency in epilepsy patients. Furthermore, in February 2024, the World Health Organization stated that approximately 50 million individuals worldwide suffer from epilepsy, with nearly 80% living in low- and middle-income nations.

Market Segment insights

Product-wise, the global bioelectric medicine segment includes implantable cardioverter defibrillators, cardiac pacemakers, cochlear implants, spinal cord stimulators, deep brain stimulators, transcutaneous electrical nerve stimulators, sacral nerve stimulators, vagus nerve stimulators, and others.

The bioelectric medicine market is divided into two types: implanted electroceutical devices and noninvasive electroceutical devices.

The Bioelectric Medicine Market has been categorized by application, including arrhythmia, pain management, sensorineural hearing loss, Parkinson's disease, tremor, depression, epilepsy, urine and fecal incontinence, among others.

The market is divided into three segments based on the end user: hospitals, research institutes, and others.

Regional insights

The study divides the market into four regions: North America, Europe, Asia-Pacific, and the rest of the world. North America's bioelectric medicine market held the greatest market share of 38.01% in 2022 and is expected to reach roughly USD 16.00 billion by 2030, growing at a 4.71% CAGR during the forecast period. However, Asia-Pacific is expected to develop at the fastest CAGR of 8.99% over the forecast period.

The future for the North American bioelectric medicine market remains positive, with continued expansion expected. Investments in healthcare infrastructure and increased awareness of modern medical solutions are projected to propel market growth even further. Both established firms and new entrants are ready to seize these possibilities, utilizing technological improvements to address the growing need for better surgical outcomes.

Europe's bioelectric medicine market accounted for the second-largest market share due to technological improvements, rising healthcare costs, and an increase in the prevalence of chronic conditions. Furthermore, the Germany bioelectric medicine market is expected to have the greatest market share, with France's bioelectric medicine market forecast to be the fastest expanding market in Europe.

The Asia-Pacific bioelectric medicine market is predicted to develop the fastest between 2023 and 2032 due to its large patient population, increased prevalence of chronic diseases, and favorable regulatory policies. Furthermore, prominent market companies are constantly expanding into this region, accelerating regional market growth. Furthermore, China's bioelectric medicine market held the greatest market share, while India's bioelectric medicine market is expected to be the fastest expanding market in the Asia-Pacific region.

Major Players

Abbott (US), Boston Scientific Corporation (US), Bortnick (Germany), Aleva Neurotherapeutics (Switzerland), Cochlear Ltd. (Australia), LivaNova PLC (UK), Medtronic (Ireland), Charco Neurotech (UK), ElectroCore, Inc. (US), and Nevro Corp (US) are some of the key companies in the Bioelectric Medicine market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 INCREASING INCIDENCES OF CHRONIC DISEASES ACROSS THE GLOBE
  • 4.2.2 RISING STRATEGIC INITIATIVES BY MARKET PLAYERS
• 4.3 RESTRAINTS
  • 4.3.1 HIGH COST ASSOCIATED WITH BIOELECTRIC MEDICINE DEVICES
• 4.4 OPPORTUNITIES
  • 4.4.1 INCREASING CLINICAL TRIALS FOR BIOELECTRIC MEDICINE
  • 4.4.2 RISING INVESTMENT IN BIOELECTRIC MEDICINE BY MARKET PLAYERS

5 MARKET FACTOR ANALYSIS

• 5.1 PORTER'S FIVE FORCES MODEL
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 BARGAINING POWER OF SUPPLIERS
  • 5.1.3 THREAT OF SUBSTITUTES
  • 5.1.4 BARGAINING POWER OF BUYERS
  • 5.1.5 INTENSITY OF RIVALRY
• 5.2 IMPACT OF COVID-19 ON THE GLOBAL BIOELECTRIC MEDICINE MARKET

6 GLOBAL BIOELECTRIC MEDICINE MARKET, BY PRODUCT

• 6.1 OVERVIEW
  • 6.1.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
  • 6.1.2 CARDIAC PACEMAKERS
  • 6.1.3 COCHLEAR IMPLANTS
  • 6.1.4 SPINAL CORD STIMULATORS
  • 6.1.5 DEEP BRAIN STIMULATORS
  • 6.1.6 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS
  • 6.1.7 SACRAL NERVE STIMULATORS
  • 6.1.8 VAGUS NERVE STIMULATORS
  • 6.1.9 OTHERS

7 GLOBAL BIOELECTRIC MEDICINE MARKET, BY TYPE

• 7.1 OVERVIEW
  • 7.1.1 IMPLANTABLE ELECTROCEUTICAL DEVICES
  • 7.1.2 NON-INVASIVE ELECTROCEUTICAL DEVICES

8 GLOBAL BIOELECTRIC MEDICINE MARKET, BY APPLICATION

• 8.1 OVERVIEW
  • 8.1.1 ARRHYTHMIA
  • 8.1.2 PAIN MANAGEMENT
  • 8.1.3 SENSORINEURAL HEARING LOSS
  • 8.1.4 PARKINSON'S DISEASE
  • 8.1.5 TREMOR
  • 8.1.6 DEPRESSION
  • 8.1.7 EPILEPSY
  • 8.1.8 URINARY AND FECAL INCONTINENCE
  • 8.1.9 OTHERS

9 GLOBAL BIOELECTRIC MEDICINE MARKET, BY END USER

• 9.1 OVERVIEW
  • 9.1.1 HOSPITALS
  • 9.1.2 RESEARCH INSTITUTES
  • 9.1.3 OTHERS

10 GLOBAL BIOELECTRIC MEDICINE MARKET, BY REGION

• 10.1 OVERVIEW
• 10.2 NORTH AMERICA
  • 10.2.1 US
  • 10.2.2 CANADA
• 10.3 EUROPE
  • 10.3.1 GERMANY
  • 10.3.2 FRANCE
  • 10.3.3 UK
  • 10.3.4 ITALY
  • 10.3.5 SPAIN
  • 10.3.6 REST OF EUROPE
• 10.4 ASIA-PACIFIC
  • 10.4.1 CHINA
  • 10.4.2 INDIA
  • 10.4.3 JAPAN
  • 10.4.4 AUSTRALIA
  • 10.4.5 SOUTH KOREA
  • 10.4.6 REST OF ASIA-PACIFIC
• 10.5 REST OF THE WORLD
  • 10.5.1 MIDDLE EAST
  • 10.5.2 AFRICA
  • 10.5.3 LATIN AMERICA
• 11.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL BIOELECTRIC MEDICINE MARKET
• 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 11.6.1 PRODUCT LAUNCH
  • 11.6.2 PRODUCT APPROVAL
  • 11.6.3 ACQUISITION
  • 11.6.4 INVESTMENT
  • 11.6.5 EXPANSION
• 11.7 MAJOR PLAYERS FINANCIAL MATRIX
  • 11.7.1 SALES (USD BILLION),
  • 11.7.2 R&D (USD BILLION),

12 COMPANY PROFILES

• 12.1 ABBOTT
  • 12.1.1 COMPANY OVERVIEW
  • 12.1.2 FINANCIAL ANALYSIS
  • 12.1.3 PRODUCTS OFFERED
  • 12.1.4 KEY DEVELOPMENTS
  • 12.1.5 SWOT ANALYSIS
  • 12.1.6 KEY STRATEGIES
• 12.2 BOSTON SCIENTIFIC CORPORATION
  • 12.2.1 COMPANY OVERVIEW
  • 12.2.2 FINANCIAL OVERVIEW
  • 12.2.3 PRODUCTS OFFERED
  • 12.2.4 KEY DEVELOPMENTS
  • 12.2.5 SWOT ANALYSIS
  • 12.2.6 KEY STRATEGIES
• 12.3 ALEVA NEUROTHERAPEUTICS
  • 12.3.1 COMPANY OVERVIEW
  • 12.3.2 FINANCIAL OVERVIEW
  • 12.3.3 PRODUCT OFFERED
  • 12.3.4 KEY DEVELOPMENTS
  • 12.3.5 KEY STRATEGIES
• 12.4 COCHLEAR LTD.
  • 12.4.1 COMPANY OVERVIEW
  • 12.4.2 FINANCIAL OVERVIEW
  • 12.4.3 PRODUCTS OFFERED
  • 12.4.4 KEY DEVELOPMENTS
  • 12.4.5 SWOT ANALYSIS
  • 12.4.6 KEY STRATEGIES
• 12.5 LIVANOVA PLC
  • 12.5.1 COMPANY OVERVIEW
  • 12.5.2 FINANCIAL OVERVIEW
  • 12.5.3 PRODUCTS OFFERED
  • 12.5.4 KEY DEVELOPMENTS
  • 12.5.5 KEY STRATEGIES
• 12.6 MEDTRONIC
  • 12.6.1 COMPANY OVERVIEW
  • 12.6.2 FINANCIAL OVERVIEW
  • 12.6.3 PRODUCTS OFFERED
  • 12.6.4 KEY DEVELOPMENTS
  • 12.6.5 SWOT ANALYSIS
  • 12.6.6 KEY STRATEGIES
• 12.7 BIOTRONIK
  • 12.7.1 COMPANY OVERVIEW
  • 12.7.2 FINANCIAL OVERVIEW
  • 12.7.3 PRODUCTS OFFERED
  • 12.7.4 KEY DEVELOPMENTS
  • 12.7.5 KEY STRATEGIES
• 12.8 CHARCO NEUROTECH
  • 12.8.1 COMPANY OVERVIEWS
  • 12.8.2 FINANCIAL OVERVIEW
  • 12.8.3 PRODUCTS OFFERED
  • 12.8.4 KEY DEVELOPMENTS
  • 12.8.5 KEY STRATEGIES
• 12.9 NEVRO CORP
  • 12.9.1 COMPANY OVERVIEWS
  • 12.9.2 FINANCIAL OVERVIEW
  • 12.9.3 PRODUCTS OFFERED
  • 12.9.4 KEY DEVELOPMENTS
  • 12.9.5 KEY STRATEGIES
• 12.10 ELECTROCORE, INC
  • 12.10.1 COMPANY OVERVIEWS
  • 12.10.2 FINANCIAL OVERVIEW
  • 12.10.3 PRODUCTS OFFERED
  • 12.10.4 KEY DEVELOPMENTS
  • 12.10.5 SWOT ANALYSIS
  • 12.10.6 KEY STRATEGIES

13 APPENDIX

• 13.1 REFERENCES
• 13.2 INTERNATIONAL ASSOCIATION FOR THE STUDY OF PAIN
• 13.3 AMERICAN PARKINSON DISEASE ASSOCIATION
• 13.4 PARKINSON'S FOUNDATION
• 13.5 ANXIETY AND DEPRESSION ASSOCIATION OF AMERICA
• 13.6 EUROPEAN ALLIANCE AGAINST DEPRESSION
• 13.7 AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS
• 13.8 THE AFRICAN SOCIETY FOR REGIONAL ANESTHESIA (AFSRA)
• 13.9 DEEP BRAIN STIMULATION NURSE ASSOCIATION (DBSNA)
• 13.10 EUROPEAN SOCIETY OF CARDIOLOGY
• 13.11 THE COCHLEAR IMPLANT GROUP OF INDIA
• 13.12 AMERICAN COCHLEAR IMPLANT ALLIANCE
• 13.13 UNITED SPINAL ASSOCIATION
• 13.14 AMERICAN SPINAL INJURY ASSOCIATION
• 13.15 NATIONAL SPINAL CORD INJURY ASSOCIATION
• 13.16 AMERICAN CLINICAL NEUROPHYSIOLOGY SOCIETY.
• 13.17 EUROPEAN ACADEMY OF NEUROLOGY (EAN)
• 13.18 CHILD NEUROLOGY SOCIETY.
• 13.19 AUSTRALIA EPILEPSY SOCIETY
• 13.20 RELATED REPORTS